China Irritable Bowel Syndrome (IBS) Market Report & Forecast 2021-2027

Publisher Name :
Date: 25-Aug-2021
No. of pages: 91
Inquire Before Buying

This report contains market size and forecasts of Irritable Bowel Syndrome (IBS) in China, including the following market information:

China Irritable Bowel Syndrome (IBS) Market Revenue, 2016-2021, 2022-2027, ($ millions)

China top five Irritable Bowel Syndrome (IBS) companies in 2020 (%)

The global Irritable Bowel Syndrome (IBS) market size is expected to growth from US$ 4130.9 million in 2020 to US$ 10960 million by 2027; it is expected to grow at a CAGR of 15.0% during 2021-2027.

The China Irritable Bowel Syndrome (IBS) market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Irritable Bowel Syndrome (IBS) Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Irritable Bowel Syndrome (IBS) Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Irritable Bowel Syndrome (IBS) Market Segment Percentages, By Type, 2020 (%)

- IBS-D Drug

- IBS-C Drug

- Others

China Irritable Bowel Syndrome (IBS) Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Irritable Bowel Syndrome (IBS) Market Segment Percentages, By Application, 2020 (%)

- Women

- Men

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Irritable Bowel Syndrome (IBS) revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Irritable Bowel Syndrome (IBS) revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Bausch Health

- Allergan

- Takeda

- Sucampo Pharmaceuticals (Mallinckrodt)

- Sebela Pharmaceuticals Inc

- Astellas Pharmaceuticals

China Irritable Bowel Syndrome (IBS) Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome (IBS) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Irritable Bowel Syndrome (IBS) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Irritable Bowel Syndrome (IBS) Overall Market Size
2.1 China Irritable Bowel Syndrome (IBS) Market Size: 2021 VS 2027
2.2 China Irritable Bowel Syndrome (IBS) Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Irritable Bowel Syndrome (IBS) Players in China Market
3.2 Top China Irritable Bowel Syndrome (IBS) Companies Ranked by Revenue
3.3 China Irritable Bowel Syndrome (IBS) Revenue by Companies
3.4 Top 3 and Top 5 Irritable Bowel Syndrome (IBS) Companies in China Market, by Revenue in 2020
3.5 Companies Irritable Bowel Syndrome (IBS) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Players in China Market
3.6.1 List of Tier 1 Irritable Bowel Syndrome (IBS) Companies in China
3.6.2 List of Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Irritable Bowel Syndrome (IBS) Market Size Markets, 2021 & 2027
4.1.2 IBS-D Drug
4.1.3 IBS-C Drug
4.1.4 Others
4.2 By Type - China Irritable Bowel Syndrome (IBS) Revenue & Forecasts
4.2.1 By Type - China Irritable Bowel Syndrome (IBS) Revenue, 2016-2021
4.2.2 By Type - China Irritable Bowel Syndrome (IBS) Revenue, 2022-2027
4.2.3 By Type - China Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Irritable Bowel Syndrome (IBS) Market Size, 2021 & 2027
5.1.2 Women
5.1.3 Men
5.2 By Application - China Irritable Bowel Syndrome (IBS) Revenue & Forecasts
5.2.1 By Application - China Irritable Bowel Syndrome (IBS) Revenue, 2016-2021
5.2.2 By Application - China Irritable Bowel Syndrome (IBS) Revenue, 2022-2027
5.2.3 By Application - China Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
6 Irritable Bowel Syndrome (IBS) Companies Profiles
6.1 Bausch Health
6.1.1 Bausch Health Company Details
6.1.2 Bausch Health Business Overview
6.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
6.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.1.5 Bausch Health Recent Developments
6.2 Allergan
6.2.1 Allergan Company Details
6.2.2 Allergan Business Overview
6.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
6.2.4 Allergan Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.2.5 Allergan Recent Developments
6.3 Takeda
6.3.1 Takeda Company Details
6.3.2 Takeda Business Overview
6.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
6.3.4 Takeda Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.3.5 Takeda Recent Developments
6.4 Sucampo Pharmaceuticals (Mallinckrodt)
6.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
6.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
6.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
6.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
6.5 Sebela Pharmaceuticals Inc
6.5.1 Sebela Pharmaceuticals Inc Company Details
6.5.2 Sebela Pharmaceuticals Inc Business Overview
6.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
6.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.5.5 Sebela Pharmaceuticals Inc Recent Developments
6.6 Astellas Pharmaceuticals
6.6.1 Astellas Pharmaceuticals Company Details
6.6.2 Astellas Pharmaceuticals Business Overview
6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
6.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021)
6.6.5 Astellas Pharmaceuticals Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Irritable Bowel Syndrome (IBS) Market Opportunities & Trends in China Market
Table 2. Irritable Bowel Syndrome (IBS) Market Drivers in China Market
Table 3. Irritable Bowel Syndrome (IBS) Market Restraints in China Market
Table 4. Key Players of Irritable Bowel Syndrome (IBS) in China Market
Table 5. Top Irritable Bowel Syndrome (IBS) Players in China Market, Ranking by Revenue (2019)
Table 6. China Irritable Bowel Syndrome (IBS) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Irritable Bowel Syndrome (IBS) Revenue Share by Companies, 2016-2021
Table 8. Companies Irritable Bowel Syndrome (IBS) Product Type
Table 9. List of Tier 1 Irritable Bowel Syndrome (IBS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Irritable Bowel Syndrome (IBS) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Irritable Bowel Syndrome (IBS) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Irritable Bowel Syndrome (IBS) Revenue (US$, Mn), 2022-2027
Table 17. Bausch Health Company Details
Table 18. Bausch Health Business Overview
Table 19. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 20. Bausch Health Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Bausch Health Recent Developments
Table 22. Allergan Company Details
Table 23. Allergan Business Overview
Table 24. Allergan Irritable Bowel Syndrome (IBS) Product
Table 25. Allergan Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Allergan Recent Developments
Table 27. Takeda Company Details
Table 28. Takeda Business Overview
Table 29. Takeda Irritable Bowel Syndrome (IBS) Product
Table 30. Takeda Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Takeda Recent Developments
Table 32. Sucampo Pharmaceuticals (Mallinckrodt) Company Details
Table 33. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
Table 34. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 35. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
Table 37. Sebela Pharmaceuticals Inc Company Details
Table 38. Sebela Pharmaceuticals Inc Business Overview
Table 39. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 40. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Sebela Pharmaceuticals Inc Recent Developments
Table 42. Astellas Pharmaceuticals Company Details
Table 43. Astellas Pharmaceuticals Business Overview
Table 44. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 45. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Astellas Pharmaceuticals Recent Developments
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Segment by Type
Figure 2. Irritable Bowel Syndrome (IBS) Segment by Application
Figure 3. China Irritable Bowel Syndrome (IBS) Market Overview: 2020
Figure 4. China Irritable Bowel Syndrome (IBS) Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Irritable Bowel Syndrome (IBS) Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2020
Figure 7. By Type - China Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 8. By Application - China Irritable Bowel Syndrome (IBS) Revenue Market Share, 2016-2027
Figure 9. Bausch Health Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Allergan Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Takeda Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs